BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21408070)

  • 1. A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection.
    O'Brien KB; Morrison TE; Dundore DY; Heise MT; Schultz-Cherry S
    PLoS One; 2011 Mar; 6(3):e17377. PubMed ID: 21408070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly pathogenic avian influenza A H5N1 and pandemic H1N1 virus infections have different phenotypes in Toll-like receptor 3 knockout mice.
    Leung YHC; Nicholls JM; Ho CK; Sia SF; Mok CKP; Valkenburg SA; Cheung P; Hui KPY; Chan RWY; Guan Y; Akira S; Peiris JSM
    J Gen Virol; 2014 Sep; 95(Pt 9):1870-1879. PubMed ID: 24878639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Cytotoxic T Cell Functions and Decreased Levels of Tissue-Resident Memory T Cells during H5N1 Infection.
    Kandasamy M; Furlong K; Perez JT; Manicassamy S; Manicassamy B
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses.
    Sakabe S; Iwatsuki-Horimoto K; Takano R; Nidom CA; Le MTQ; Nagamura-Inoue T; Horimoto T; Yamashita N; Kawaoka Y
    J Gen Virol; 2011 Jun; 92(Pt 6):1428-1434. PubMed ID: 21367984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.
    Wu CY; Yeh YC; Chan JT; Yang YC; Yang JR; Liu MT; Wu HS; Hsiao PW
    PLoS One; 2012; 7(8):e42363. PubMed ID: 22879951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus.
    Chang H; Huang C; Wu J; Fang F; Zhang W; Wang F; Chen Z
    Virol J; 2010 Aug; 7():197. PubMed ID: 20727202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages.
    Lee SM; Gardy JL; Cheung CY; Cheung TK; Hui KP; Ip NY; Guan Y; Hancock RE; Peiris JS
    PLoS One; 2009 Dec; 4(12):e8072. PubMed ID: 20011590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential host determinants contribute to the pathogenesis of 2009 pandemic H1N1 and human H5N1 influenza A viruses in experimental mouse models.
    Otte A; Sauter M; Alleva L; Baumgarte S; Klingel K; Gabriel G
    Am J Pathol; 2011 Jul; 179(1):230-9. PubMed ID: 21703405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice.
    Perrone LA; Plowden JK; GarcĂ­a-Sastre A; Katz JM; Tumpey TM
    PLoS Pathog; 2008 Aug; 4(8):e1000115. PubMed ID: 18670648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian innate resistance to highly pathogenic avian influenza H5N1 virus infection is mediated through reduced proinflammation and infectious virus release.
    Nelli RK; Dunham SP; Kuchipudi SV; White GA; Baquero-Perez B; Chang P; Ghaemmaghami A; Brookes SM; Brown IH; Chang KC
    J Virol; 2012 Sep; 86(17):9201-10. PubMed ID: 22718824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular response to influenza virus infection: a potential role for autophagy in CXCL10 and interferon-alpha induction.
    Law AH; Lee DC; Yuen KY; Peiris M; Lau AS
    Cell Mol Immunol; 2010 Jul; 7(4):263-70. PubMed ID: 20473322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus.
    Zhao G; Sun S; Du L; Xiao W; Ru Z; Kou Z; Guo Y; Yu H; Jiang S; Lone Y; Zheng BJ; Zhou Y
    Virol J; 2010 Jul; 7():151. PubMed ID: 20624292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.
    Morgan SB; Hemmink JD; Porter E; Harley R; Shelton H; Aramouni M; Everett HE; Brookes SM; Bailey M; Townsend AM; Charleston B; Tchilian E
    J Immunol; 2016 Jun; 196(12):5014-23. PubMed ID: 27183611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immune responses to influenza A H5N1: friend or foe?
    Peiris JS; Cheung CY; Leung CY; Nicholls JM
    Trends Immunol; 2009 Dec; 30(12):574-84. PubMed ID: 19864182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses.
    Geiler J; Michaelis M; Sithisarn P; Cinatl J
    Med Microbiol Immunol; 2011 Feb; 200(1):53-60. PubMed ID: 20865277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.
    Budimir N; Huckriede A; Meijerhof T; Boon L; Gostick E; Price DA; Wilschut J; de Haan A
    PLoS One; 2012; 7(1):e30898. PubMed ID: 22303469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Evolution of the 2009 Pandemic H1N1 Influenza Virus NS1 and PA in Humans.
    Nogales A; Martinez-Sobrido L; Chiem K; Topham DJ; DeDiego ML
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo.
    Teng O; Chen ST; Hsu TL; Sia SF; Cole S; Valkenburg SA; Hsu TY; Zheng JT; Tu W; Bruzzone R; Peiris JSM; Hsieh SL; Yen HL
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
    Van Reeth K; Braeckmans D; Cox E; Van Borm S; van den Berg T; Goddeeris B; De Vleeschauwer A
    Vaccine; 2009 Oct; 27(45):6330-9. PubMed ID: 19840669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.